L3Harris earnings on deck as missile unit expansion takes shape

L3Harris is expected to report Q1 EPS of $2.52 on revenue of $5.43 billion, implying 4.56% earnings growth and 5.85% sales growth year over year, but both are expected to decline sequentially from Q4. Investors are focused on the $1 billion Department of War investment in Missile Solutions, the planned 2H 2026 IPO of that segment, and the more than $1 billion propulsion facilities expansion that should add over 350 jobs. Wall Street remains constructive, with 15 buys, six holds, and a $392.16 consensus target, or about 21% upside from the current $324.88 share price.

Analysis

The setup is less about this quarter and more about whether LHX can translate a defense-cycle backlog into a higher-multiple industrial story. The market is implicitly paying for a clean separation of Missile Solutions plus a credible ramp in propulsion capacity; if execution slips, the stock is vulnerable because the valuation already embeds a growth-and-quality premium versus legacy primes. The key second-order effect is that federal capital is being used to de-risk capacity expansion, which should compress financing risk but also raises the bar for future standalone margins and IPO economics.

Near term, the main risk is not demand but mix and throughput: new plant spending creates a temporary drag before it generates revenue, so any sequential revenue softness can be read as under-absorption rather than weakness in end demand. That matters because defense names often get punished when investors see capex ahead of recognized revenue, especially if management leans too optimistic on the 2026 separation timeline. Over the next 1-2 quarters, the stock will likely trade on evidence of backlog conversion and margin slope more than headline EPS.

Consensus appears complacent on two fronts. First, the IPO angle may be over-credited: carving out a missile business can unlock value, but it also removes a high-growth asset from the diversified parent, which can lower the multiple on the remaining mix if corporate synergies are overstated. Second, a premium multiple near 28x forward earnings leaves little room for operational hiccups; if guidance is merely reaffirmed rather than raised, the market may treat that as a disappointment. The counterintuitive bull case is that any incremental visibility into long-dated propulsion capacity could trigger estimate revisions higher for 2027, which is where the real rerating would come from.

Key Decisions for Investors

• Go long LHX only on a post-earnings pullback if management confirms backlog conversion and keeps the 2026 separation on track; use a 3-6 month horizon and demand at least 15% upside to justify the premium multiple.
• Buy LHX Jan-2026 or Jan-2027 call spreads to express the IPO/capacity-upside story with defined risk; this is cleaner than stock because the near-term execution risk is high.
• Pair trade: long LHX / short a basket of slower-growth defense primes with lower organic growth visibility over the next 1-2 quarters; the relative trade works if missile and propulsion exposure continues to attract a structural multiple premium.
• If guidance comes in only in-line or below, fade the name via short-dated puts or a tactical short for 1-4 weeks; the setup is vulnerable to de-rating because expectations are already elevated.
• Monitor supplier names tied to propulsion and facility build-out for second-order beneficiaries; any confirmed ramp could support a trade in industrial automation/equipment suppliers over the next 6-12 months.